Jazz Pharmaceuticals

Stock since the trade +0.3% · S&P 500 +2.7% · to Oct 5

Jazz Pharmaceuticals's Chief Commercial Officer sold $1.63M of Jazz Pharmaceuticals shares. Nobody planned it ahead of time.

Stock since the trade −1.6% · S&P 500 +3.9% · to Oct 5

A board member of Jazz Pharmaceuticals sold $662K of Jazz Pharmaceuticals shares. Nobody planned it ahead of time.

Stock since the trade −1.6% · S&P 500 +3.9% · to Oct 5

A board member of Jazz Pharmaceuticals sold $482K of Jazz Pharmaceuticals shares. Nobody planned it ahead of time.

Stock since the trade +27.3% · S&P 500 +14.2% · to Oct 5

Jazz Pharmaceuticals's SVP, Chief Accounting Officer sold $235K of Jazz Pharmaceuticals shares. Nobody planned it ahead of time.

Stock since the trade +24.2% · S&P 500 +12.9% · to Oct 5

A board member of Jazz Pharmaceuticals sold $656K of Jazz Pharmaceuticals shares. Nobody planned it ahead of time.

Stock since the trade +24.2% · S&P 500 +12.9% · to Oct 5

Jazz Pharmaceuticals's SVP, Chief Accounting Officer sold $213K of Jazz Pharmaceuticals shares. Nobody planned it ahead of time.